Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.69B |
| 2 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.32B |
| 3 |
Vanguard Total Bond Market
BND
|
+$1.21B |
| 4 |
SPDR Gold Trust
GLD
|
+$970M |
| 5 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$842M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.66B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$5.23B |
| 3 |
Accenture
ACN
|
+$1.14B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.13B |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$635M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.44% |
| 2 | Financials | 11.15% |
| 3 | Consumer Discretionary | 8.06% |
| 4 | Healthcare | 8.02% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
Transportadora de Gas del Sur
TGS
$4.44B
| $15.2M | ﹤0.01% |
487,494
+76,305
| +19% | +$2.16M |
|
3177
Fidelity Limited Term Bond ETF
FLTB
$415M
| $15.2M | ﹤0.01% |
299,141
+61,785
| +26% | +$3.14M |
|
3178
National Bank Holdings
NBHC
$1.9B
| $15.1M | ﹤0.01% |
398,516
+83,267
| +26% | +$3.14M |
|
|
INVX
3179
Innovex International
INVX
$1.79B
| $15.1M | ﹤0.01% |
692,580
+85,839
| +14% | +$1.79M |
|
3180
Freedom Holding
FRHC
$9.84B
| $15.1M | ﹤0.01% |
124,308
-71,579
| -37% | -$10.4M |
|
3181
iShares US Regional Banks ETF
IAT
$682M
| $15.1M | ﹤0.01% |
274,140
-20,827
| -7% | -$1.08M |
|
|
SPPP
3182
Sprott Physical Platinum and Palladium Trust
SPPP
$566M
| $15.1M | ﹤0.01% |
896,321
+528,059
| +143% | +$7.8M |
|
3183
Dave Inc
DAVE
$5.17B
| $15.1M | ﹤0.01% |
68,155
-49,133
| -42% | -$10.6M |
|
3184
iShares CMBS ETF
CMBS
$474M
| $15.1M | ﹤0.01% |
306,977
+23,956
| +8% | +$1.18M |
|
|
NBP
3185
NovaBridge Biosciences American Depositary Shares
NBP
$202M
| $15.1M | ﹤0.01% |
3,785,502
+1,553,462
| +70% | +$6.87M |
|
|
DX
3186
Dynex Capital
DX
$3.07B
| $15.1M | ﹤0.01% |
1,074,301
-52,775
| -5% | -$712K |
|
3187
Nuveen California Municipal Value Fund
NCA
$298M
| $15M | ﹤0.01% |
1,681,135
-131,621
| -7% | -$1.18M |
|
3188
LGI Homes
LGIH
$1.43B
| $15M | ﹤0.01% |
350,103
-136,003
| -28% | -$6.38M |
|
3189
Theravance Biopharma
TBPH
$875M
| $15M | ﹤0.01% |
803,119
+203,568
| +34% | +$3.38M |
|
|
SCHQ
3190
Schwab Long-Term US Treasury ETF
SCHQ
$809M
| $15M | ﹤0.01% |
473,990
-139,510
| -23% | -$4.51M |
|
3191
Danaos Corp
DAC
$2.56B
| $15M | ﹤0.01% |
159,431
-18,464
| -10% | -$1.7M |
|
3192
Gabelli Equity Trust
GAB
$1.76B
| $15M | ﹤0.01% |
2,433,594
+114,995
| +5% | +$698K |
|
3193
Digi International
DGII
$2.53B
| $15M | ﹤0.01% |
345,827
+31,140
| +10% | +$1.25M |
|
3194
Invesco Leisure and Entertainment ETF
PEJ
$263M
| $15M | ﹤0.01% |
243,853
-254,005
| -51% | -$15.1M |
|
3195
iQIYI
IQ
$1.21B
| $15M | ﹤0.01% |
7,787,808
-7,272,007
| -48% | -$15.6M |
|
|
CTLP
3196
DELISTED
Cantaloupe
CTLP
| $15M | ﹤0.01% |
1,407,841
-101,647
| -7% | -$1.08M |
|
|
BWG
3197
BrandywineGLOBAL Global Income Opportunities Fund
BWG
$129M
| $14.9M | ﹤0.01% |
1,784,426
-85,702
| -5% | -$727K |
|
|
USAR
3198
USA Rare Earth Inc
USAR
$3.44B
| $14.9M | ﹤0.01% |
1,253,579
+869,789
| +227% | +$16.6M |
|
3199
Kimbell Royalty Partners
KRP
$1.43B
| $14.9M | ﹤0.01% |
1,267,043
-358,455
| -22% | -$4.59M |
|
3200
iShares MSCI Peru and Global Exposure ETF
EPU
$530M
| $14.9M | ﹤0.01% |
205,908
+32,648
| +19% | +$2.11M |
|
Similar funds
Morgan Stanley's Q4 2025 Portfolio in Review
As of Q4 2025, Morgan Stanley held 8,587 positions worth $1.67T, up 1.4% from $1.65T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Morgan Stanley's Q4 2025 filing shows 427 new, 3,948 increased, 2,961 reduced and 384 closed positions. Its largest new stake was Medline Inc: 15,162,060 shares worth $637M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $7.66B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q4 2025 buy was Medline Inc: 15,162,060 shares worth $637M.
- Morgan Stanley added most to Vanguard FTSE Developed Markets ETF in Q4 2025, an estimated $1.69B increase.
- Morgan Stanley's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.66B.
- Morgan Stanley fully exited Mr. Cooper in Q4 2025, selling an estimated $312M.
- Morgan Stanley's ten largest holdings make up 22% of its $1.67T portfolio in Q4 2025.
- Morgan Stanley opened 427 new positions and closed 384 in Q4 2025.
- Morgan Stanley's portfolio value rose 1.4% quarter-over-quarter to $1.67T.
Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.